Leveraging Cerner Real World Data and the Learning Health Network

  • December 3, 2020 from 12:00-1:00pm
  • Please RSVP by emailing Lisa Maturo at Lisa.M.Maturo@christianacare.org.
  • Please include your full name, email address, and institution/organization. 
  • We will provide instructions on obtaining CME credit for attendance.

In this talk, I will describe Cerner Real World Data and the Learning Health Network, sharing how ChristianaCare can leverage these solutions for research. Cerner Real-World Data is a national, de-identified, person-centric data set solution that enables researchers to leverage longitudinal record data from contributing organizations. With Real-World Data, volumes of de-identified information can be accessed for analysis and surveillance to help inform health care. The Learning Health Network is a network of more than 50 health systems nationwide dedicated to data sharing to advance clinical research. Member health systems receive complimentary access to a national set of standardized de-identified data and opportunities to engage in research efforts with a range of benefits including revenue generation and clinical support tools. As a member of the Learning Health Network, ChristianaCare can opt-in to participate in research studies, access Cerner Real World Data, and collaborate with other health systems in the Network.

Meet the Speaker

Kimberly Carlson, MPH

Kimberly Carlson, MPH, is a Senior Clinical Researcher at Cerner Corporation where she leverages evidence-based, data-driven ways to improve the health of people and communities.  She coordinates client relationships and research opportunities in the Cerner Learning Health Network, a national network utilizing Real World Data to enhance & accelerate clinical research. She also serves as Cerner’s Principal Investigator for the HIV Outpatient Study, a longitudinal observational cohort study funded by the Centers for Disease Control and Prevention since 1993. Her additional research interests & expertise include clinical training, reproductive health, monitoring and evaluation, infectious diseases, and vaccine development.

This activity has been approved for AMA PRA Category 1 Credit

Stay Connected

Join the ACCEL newsletter and keep up to date with the latest news, events and funding opportunities!

[yikes-mailchimp form="1"]